Regulus Therapeutics Inc (NASDAQ:RGLS)
| 1.36 BATS BZX Real-Time Price As of 11:16am ET |  +0.06 / +4.62%Today’s Change | 0.76 Today|||52-Week Range 3.00 | -0.73% Year-to-Date |
Latest RGLS News | Press Releases
No recent news for Regulus Therapeutics Inc.
Today’s Trading
| Previous close | 1.30 |
| Today’s open | 1.35 |
| Day’s range | 1.35 - 1.36 |
| Volume | 30 |
| Average volume (3 months) | 58,071 |
| Market cap | $25.7M |
Data as of 11:16am ET, 06/05/2023
Growth & Valuation
| Earnings growth (last year) | +42.80% |
| Earnings growth (this year) | +11.29% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.67 |
Competitors
Data as of 12:51pm ET, 06/05/2023
Financials
| Next reporting date | August 10, 2023 |
| EPS forecast (this quarter) | -$0.41 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$28.3M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
